Sturge–Weber syndrome: updates in translational neurology
Abstract Sturge–Weber syndrome (SWS) is a rare congenital neurovascular disorder that initially presents with a facial port-wine birthmark (PWB) and…
2D demodulation data treatment
Patterns and Challenges in Help-Seeking for Addiction among Men: A Systematic Review
Abstract Background/Objectives: Addictive and substance-related disorders represent a substantial public health challenge, marked by rising incidence and prevalence rates. Men…
Experiences and Comfort of Young Cancer Patients Discussing Cannabis with Their Providers: Insights from a Survey at an NCI-Designated Cancer Center
Abstract Cannabis use among cancer patients for managing treatment-related symptoms is increasing, yet little is known about patterns in patient-provider…
Long-Term Treatment for Unspecified Anxiety Disorders with Cannabidiol: A Retrospective Case Series from Real-World Evidence in Colombia
Abstract Introduction: Preclinical and clinical evidence has elucidated that cannabis-based medical formulations (CBMFs) may display anxiolytic, antidepressive, and neuroprotective properties.…
Self-Medication Paths
Abstract Objectives: Cannabis is used by one-third of people living with chronic pain to alleviate their symptoms despite warnings from…
Therapeutic potential of cannabis for surgical wound healing in rats
Abstract This study was conducted to evaluate the wound-healing activities of a Cannabis sativa L. plant extract and cannabidiol on…
The Perspective of Cannabidiol in Psoriasis Therapy
Abstract Psoriasis is a chronic skin condition that can significantly impact the quality of life of those affected. As an…
Effectiveness of cannabis use and cannabis use disorder interventions: a European and international data synthesis
Abstract This data synthesis examined the effectiveness of behavioural and pharmacological approaches for cannabis treatment. We integrated findings from high…
An observational time-series study on the behavioral effects of adjunctive artisanal cannabidiol use by adults with treatment resistant epilepsies
Abstract Background: For approximately 30% of people with epilepsy, seizures are not well-controlled by anti-seizure medication (ASM). This condition, called…
Pharmacodynamic rationale for the choice of antiseizure medications in the paediatric population
Abstract In the landscape of paediatric epilepsy treatment, over 20 anti-seizure medications (ASMs) have gained approval from Drug Regulatory Agencies,…